NCT00000135View on ClinicalTrials.gov

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

August 31, 1996

Study Completion Date

August 31, 1996

Conditions
HIV InfectionsCytomegalovirus Retinitis
Interventions
DRUG

MSL-109

60 mg, IV (in vein) every two weeks, treatment continued until death or common closeout.

OTHER

Placebo

60 mg, IV (in vein) every two weeks, treatment continued until death or common closeout.

All Listed Sponsors
lead

Johns Hopkins Bloomberg School of Public Health

OTHER